Dhami government imposed a ban on five medicines of Patanjali in Uttarakhand, Ramdev said – copy of the order has not been received yet
Citing misleading advertisements, the Ayurveda and Unani Licensing Authority, Uttarakhand has asked Divya Pharmacy, which makes Patanjali products, to stop the production of five medicines. In protest, yoga guru Baba Ramdev has accused an ‘anti-Ayurveda drug mafia’ of conspiring. The company said that it has not received a copy of the order given in the newspaper report, but the involvement of the anti-Ayurveda drug mafia is clear in it. With the help of more than 500 scientists, Ayurveda tradition is followed with the highest research and quality, following all statutory procedures and the prescribed standards, meeting international standards. The letter which was written in a conspiracy and circulated in the media on 9.11.2022 in a manner sponsored by Ayurveda and Unani Seva Uttarakhand has not been made available to Patanjali Sansthan in any form till now.
The company further said, ‘Either the department should rectify its mistake and take appropriate action against the person involved in this conspiracy, otherwise the institution will take legal action to punish the persons responsible for this conspiracy including compensation for the institutional damage caused to Patanjali.’ was told in several newspaper reports that the Uttarakhand authority has asked Ramdev’s Patanjali Ayurved to stop manufacturing five products the company has promoted to treat blood pressure, diabetes, goiter, glaucoma and high cholesterol. as has been done.
According to a report, the Ayurveda and Unani Licensing Authority in Dehradun, Uttarakhand has directed Divya Pharmacy to stop production of Madhugrit, Igrit, Thyrogrit, BPgrit and Lipidome. The order was issued by Dr GCS Jangpangi, Licensing Officer, Uttarakhand Ayurvedic and Unani Services and accused Patanjali of misleading advertisements. The action is based on a complaint filed in July by Kerala-based ophthalmologist KV Babu. KV Babu had sent another complaint to the State Licensing Authority (SLA) via email on October 11.
